Primary Sjögren's Syndrome research hub
4 indexed studies · 2 currently recruiting
- recruitingPHASE2
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
This study is testing a new drug, IMVT-1402, for adults with a moderate to severe form of Sjögren's Syndrome. It aims to see if the drug is safe and helps reduce symptoms compared to a dummy drug (placebo) over 24 weeks.
United States · Argentina · Brazil - ongoing, recruitingTherapeutic exploratory (Phase II)
Leflunomide and Hydroxychloroquine combination therapy for primary Sjögren’s Syndrome; RepurpSS-II study
This study, called RepurpSS-II, is looking at how a combination of two existing medicines, Leflunomide and Hydroxychloroquine, might help people with primary Sjögren's Syndrome. Researchers want to see if these drugs can reduce disease activity and improve symptoms like dryness compared to a dummy pill.
Netherlands - ongoing, recruitingTherapeutic exploratory (Phase II)
ARGX-113-2211: Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients with primary Sjögren’s Syndrome (pSS) who complete qualifying efgartigimod pSS studies
This study is looking at how safe a new medicine called efgartigimod is for adults with primary Sjögren's Syndrome. It's for people who have already taken part in a related study on this medicine. We want to see if there are any side effects.
Poland · Hungary · Belgium - recruiting
The ASSESS National Multi-center Prospective Cohort
This study, called ASSESS, follows people in France with Primary Sjögren's Syndrome over 20 years to understand how the condition develops and if they get other health problems, especially a type of cancer called lymphoma. It helps doctors learn more about this long-term condition.
France